Search Results
Feb 19, 2026, 13:31 ET Cambrex annonce que Song Lin, professeur à Cornell, est le lauréat du prix Snapdragon 2025 de l'innovation en technologie de la chimie
19 février 2026 /PRNewswire/ -- Cambrex, une organisation mondiale de développement et de fabrication sous contrat (CDMO) et Snapdragon Chemistry, une société de Cambrex, sont fières d'annoncer que le Dr Song Lin, professeur de chimie et de biologie chimique à la faculté
More news about: Cambrex
Feb 19, 2026, 10:30 ET Veterinary Contract Manufacturing & Research Market worth $9.24 billion by 2031 | MarketsandMarkets™
(2026–2031): 7.7%Veterinary Contract Manufacturing & Research Market Trends & Insights:By service, the CDMO services segment is projected to register the highest CAGR of 8.1%.By product type, the medicines segment dominated the market with 80.0% share
More news about: MarketsandMarkets
Feb 19, 2026, 07:07 ET Univar Solutions rozširuje portfólio ingrediencií o exkluzívnu zmluvu na distribúciu kyseliny glykolovej v regióne EMEA
prostredníctvom svojej divízie Ingredients + Specialties nové exkluzívne distribučné partnerstvo so skupinou CABB Group, popredným poskytovateľom zmluvnej výroby (CDMO) a jemnej chémie, ktorý sa špecializuje na zákazkové aktívne zložky a roztoky vysokej čistoty pre biologické vedy, osobnú starostlivosť, pestovanie
More news about: Univar Solutions LLC
Feb 19, 2026, 06:00 ET Cambrex Announces Cornell Professor Song Lin as Recipient of the 2025 Snapdragon Prize for Innovation in Chemistry Technology
N.J., Feb. 19, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) and Snapdragon Chemistry, a Cambrex company, are proud to announce that Dr. Song Lin, Tisch University Professor in chemistry and chemical biology
More news about: Cambrex
Feb 19, 2026, 06:00 ET Cambrex Announces Cornell Professor Song Lin as Recipient of the 2025 Snapdragon Prize for Innovation in Chemistry Technology
N.J., Feb. 19, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO) and Snapdragon Chemistry, a Cambrex company, are proud to announce that Dr. Song Lin, Tisch University Professor in chemistry and chemical biology
More news about: Cambrex
Feb 19, 2026, 06:00 ET Cambrex anuncia al profesor Song Lin como ganador del Premio Snapdragon 2025
19 de febrero de 2026 /PRNewswire/ -- Cambrex, una organización líder mundial en desarrollo y fabricación por contrato (CDMO) y Snapdragon Chemistry, una empresa de Cambrex, se enorgullecen de anunciar que el doctor Song Lin, profesor de química y biología química de la Universidad
More news about: Cambrex
Feb 19, 2026, 00:22 ET Univar Solutions расширяет ассортимент ингредиентов, заключив эксклюзивное соглашение о дистрибуции гликолевой кислоты в регионе EMEA
дистрибьюторском партнерстве через свое подразделение Ingredients + Specialties с компанией CABB Group, ведущим поставщиком услуг контрактного производства (CDMO) и высококачественных химикатов, специализирующимся на производстве активных ингредиентов по специальным заказам и химически чистых решениях для медико-биологической
More news about: Univar Solutions LLC
Feb 18, 2026, 14:43 ET BGL Announces the Sale of Western Botanicals to The Riverside Company
leading Vitamins, Minerals, and Supplements (VMS) Contract Development and Manufacturing Organization (CDMO), to The Riverside Company (Riverside). This represents BGL's third transaction in the CDMO subsector and fourth transaction within the broader VMS industry.
More news about: Brown Gibbons Lang & Company
Feb 18, 2026, 08:43 ET Univar Solutions erweitert sein Portfolio an Inhaltsstoffen durch einen exklusiven Vertriebsvertrag für Glykolsäure in EMEA
Geschäftsbereich Ingredients + Specialties eine neue exklusive Vertriebspartnerschaft mit der CABB Group bekannt, einem führenden Anbieter von Auftragsfertigung (CDMO) und Feinchemikalien, der sich auf maßgeschneiderte Wirkstoffe und hochreine Lösungen für Life Science, Körperpflege, Pflanzenbau und Spezialanwendungen
More news about: Univar Solutions LLC
Feb 18, 2026, 07:04 ET Univar Solutions rozszerza ofertę składników dzięki umowie na wyłączność na dystrybucję kwasu glikolowego w regionie EMEA
partnerstwa dystrybucyjnego na wyłączność w zakresie składników i produktów specjalistycznych z CABB Group - uznanym dostawcą usług produkcji kontraktowej (CDMO) i specjalistycznych środków chemicznych, wyspecjalizowanym w spersonalizowanych składnikach aktywnych oraz rozwiązaniach zapewniających wysoki poziom
More news about: Univar Solutions LLC
Feb 18, 2026, 07:03 ET Univar Solutions Expands Ingredient Portfolio with Exclusive Glycolic Acid Distribution Agreement in EMEA
exclusive distribution partnership through its Ingredients + Specialties division with the CABB Group, a leading provider of contract manufacturing (CDMO) and fine chemicals, specializing in customized active ingredients and high-purity solutions for life science, personal care, crop science, and specialty applications.
More news about: Univar Solutions LLC
Feb 18, 2026, 07:03 ET Univar Solutions Expands Ingredient Portfolio with Exclusive Glycolic Acid Distribution Agreement in EMEA
exclusive distribution partnership through its Ingredients + Specialties division with the CABB Group, a leading provider of contract manufacturing (CDMO) and fine chemicals, specializing in customized active ingredients and high-purity solutions for life science, personal care, crop science, and specialty applications.
More news about: Univar Solutions LLC
Feb 18, 2026, 07:03 ET Univar Solutions amplía su cartera de ingredientes con acuerdo exclusivo de distribución de ácido glicólico
acuerdo de distribución exclusivo a través de su división Ingredientes + Especialidades con CABB Group, proveedor líder de fabricación por contrato (CDMO) y productos químicos finos, especializado en ingredientes activos personalizados y soluciones de alta pureza para las ciencias de la vida, el cuidado
More news about: Univar Solutions LLC
Feb 17, 2026, 10:01 ET Companion Animal Diagnostic Market worth $5.40 billion by 2031 | MarketsandMarkets™
focus on innovative platforms, such as novel biologics, gene-based therapies, advanced formulations, and digital health tools, drives high demand for CDMO and CRO support across early-stage R&D, scale-up, and clinical studies. With strong investor interest and a surge in new pet health and livestock
More news about: MarketsandMarkets
Feb 17, 2026, 08:00 ET OFD Life Sciences Expands Leadership as Demand for Lyophilization Accelerates
than 15 years of experience in PMO development, risk-driven portfolio governance, and customer-centered delivery, Grosso is deeply familiar with the CDMO setting and brings extensive knowledge to the role. Her background in continuous improvement, including her Six Sigma Black Belt, has contributed to
More news about: OFD Life Sciences
Feb 17, 2026, 08:00 ET Andelyn Biosciences to Apply the AAV Curator® Platform to Manufacture Clinical Grade AAV for Drake Rayden Foundation for the Treatment of Nonketotic Hyperglycinemia
patient-first approach, Andelyn continues to serve as the CDMO partner of choice for organizations advancing life-changing gene therapies.About Andelyn Biosciences, Inc.Andelyn Biosciences is a full-service cell and gene therapy CDMO focused on the development, characterization, and production
More news about: Andelyn Biosciences
Feb 17, 2026, 07:00 ET Scinai Announces Completion of Acquisition of Recipharm Israel Ltd. and Strategic Commercial Collaboration with Recipharm
compliant with the continued listing requirements of Nasdaq; lower than anticipated revenues of Scinai's CDMO business in 2025 and thereafter, failure to sign agreements with other potential clients of the CDMO business; failure to receive grants under the EU STEP program or a delay in receiving grant decisions;
More news about: Scinai Immunotherapeutics Ltd.
Feb 12, 2026, 13:00 ET KBroVet® (potassium bromide chewable tablets) Becomes First FDA Fully Approved Pharmaceutical For The Control of Seizures Associated with Idiopathic Epilepsy in Dogs
cats, dogs, and horses and is owned by PBI-Gordon Companies, Inc. Pegasus provides full-service Contract Development and Manufacturing Organization (CDMO) focusing on the development and manufacturing with full turn-key technical services in an FDA-registered facility that is in compliance with current
More news about: Pegasus/PRN Pharmacal
Feb 12, 2026, 10:15 ET Leukapheresis Market worth $138.7 million by 2031 | MarketsandMarkets™
and Canada. Certain main infrastructure features like FACT, accredited transplant programs, FDA, authorized CAR-T treatment centers, and large-scale CDMO capabilities are significant factors for the continuous demand for leukapheresis. Besides, strong NIH funding, active enrollment in early- and late-stage
More news about: MarketsandMarkets
Feb 11, 2026, 22:48 ET WuXi Vaccines Receives Brazil's ANVISA GMP Certification
/PRNewswire/ -- WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today that it has received Good Manufacturing Practices (GMP) certification for its fill and finish facility (DP17) in Suzhou from Brazil's
More news about: WuXi Vaccines
Feb 10, 2026, 11:17 ET Made Scientific and Streamline Bio Launch Exclusive Early Adopter Program to Advance AI-Driven Robotic Automation for Cell Therapy Manufacturing
Partnership designates Made Scientific as exclusive cell therapy CDMO partner for Streamline Bio's platform, accelerating development of autonomous manufacturing workflows in GMP cleanroom environmentsPRINCETON, N.J. and CAMBRIDGE, Mass., Feb.
More news about: Made Scientific, Inc.
Feb 10, 2026, 09:00 ET AsymBio etabliert integrierte Technologieplattformen, die den gesamten Lebenszyklus der biopharmazeutischen Entwicklung abdecken
innovativer Therapien zu unterstützen.Über AsymBioAsymBio konzentriert sich ausschließlich auf biopharmazeutische CDMO-Dienstleistungen. Das Unternehmen bietet CDMO-Dienstleistungen aus einer Hand, von der frühen Entwicklungsphase bis zur klinischen, toxikologischen und kommerziellen Herstellung.
More news about: AsymBio
Feb 10, 2026, 09:00 ET AsymBio Establishes Integrated Technology Platforms Spanning the Full Biopharmaceutical Development Lifecycle
commercialization of innovative therapies.About AsymBioAsymBio focuses exclusively on biopharmaceutical CDMO services. The company delivers one-stop CDMO services from early-stage development to clinical, toxicology, and commercial-scale manufacturing. AsymBio is also expanding beyond
More news about: AsymBio
Feb 10, 2026, 09:00 ET AsymBio establece plataformas tecnológicas integradas para el desarrollo biofarmacéutico
fiable de terapias innovadoras.Acerca de AsymBioAsymBio se centra exclusivamente en servicios de CDMO biofarmacéuticos. La compañía ofrece servicios integrales de CDMO, desde el desarrollo inicial hasta la fabricación clínica, toxicológica y a escala comercial. AsymBio también se está
More news about: AsymBio
Feb 10, 2026, 09:00 ET AsymBio crée des plates-formes technologiques intégrées couvrant l'ensemble du cycle de développement biopharmaceutique
fiable de thérapies innovantes.À propos d'AsymBioAsymBio se concentre exclusivement sur les services CDMO biopharmaceutiques. L'entreprise propose des services CDMO complets, du développement précoce à la fabrication à l'échelle commerciale, en passant par les essais cliniques et la
More news about: AsymBio